Omkar Pharmachem Ltd Reports Q3 and Nine Months Results for 2025

Omkar Pharmachem Ltd has reported its unaudited financial results for the quarter and nine months ended on 31st December 2025. The company's revenue from operations stands at Rs. 1,008.37 lakhs for the quarter and Rs. 3,794.00 lakhs for the nine months period. The total expenses for the quarter are Rs. 1,065.00 lakhs and Rs. 3,964.22 lakhs for the nine months period. The company reported a profit before tax of Rs. 4.22 lakhs for the quarter and Rs. 100.15 lakhs for the nine months period. The earning per share (EPS) before and after extraordinary items is Rs. 6.91 and Rs. 18.48 respectively.